Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Continuing Cetuximab Plus Chemotherapy After First Progression in Wild-type KRAS, NRAS and BRAF V600E Metastatic Colorectal Cancer

NCT04718038 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT04718038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04718038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Continuing Cetuximab Plus Chemotherapy After First Progression in Wild-type KRAS, NRAS and BRAF V600E Metastatic Colorectal Cancer
Lead sponsor
Henan Cancer Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2016
Completion date
September 1, 2020
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

wild-type kras,nras and braf v600e metastatic colorectal cancer